Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors

Brain serotonin-6 receptor (5-HT6R) is the one of the most recently identified serotonin receptors. Accumulating evidence suggests that it is a potent therapeutic target for psychiatric and neurological diseases. Since [18F]2FNQ1P was recently proposed as the first fluorinated positron emission tomo...

Full description

Bibliographic Details
Main Authors: Véronique Sgambato-Faure, Thierry Billard, Elise Météreau, Sandra Duperrier, Sylvain Fieux, Nicolas Costes, Léon Tremblay, Luc Zimmer
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-07-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00471/full
_version_ 1818364591485222912
author Véronique Sgambato-Faure
Véronique Sgambato-Faure
Thierry Billard
Thierry Billard
Elise Météreau
Elise Météreau
Sandra Duperrier
Sandra Duperrier
Sylvain Fieux
Sylvain Fieux
Nicolas Costes
Léon Tremblay
Léon Tremblay
Luc Zimmer
Luc Zimmer
Luc Zimmer
Luc Zimmer
author_facet Véronique Sgambato-Faure
Véronique Sgambato-Faure
Thierry Billard
Thierry Billard
Elise Météreau
Elise Météreau
Sandra Duperrier
Sandra Duperrier
Sylvain Fieux
Sylvain Fieux
Nicolas Costes
Léon Tremblay
Léon Tremblay
Luc Zimmer
Luc Zimmer
Luc Zimmer
Luc Zimmer
author_sort Véronique Sgambato-Faure
collection DOAJ
description Brain serotonin-6 receptor (5-HT6R) is the one of the most recently identified serotonin receptors. Accumulating evidence suggests that it is a potent therapeutic target for psychiatric and neurological diseases. Since [18F]2FNQ1P was recently proposed as the first fluorinated positron emission tomography (PET) radioligand for this receptor, the objective of the present study was to demonstrate its suitability for 5-HT6R neuroimaging in primates. [18F]2FNQ1P was characterized by in vitro autoradiography and in vivo PET imaging in cynomolgus monkeys. Following in vivo PET imaging, tracer binding indices were computed using the simplified reference tissue model and Logan graphical model, with cerebellum as reference region. The tracer binding reproducibility was assessed by test–retest in five animals. Finally, specificity was assessed by pre-injection of a 5-HT6R antagonist, SB258585. In vitro, results showed wide cerebral distribution of the tracer with specificity toward 5-HT6Rs as binding was effectively displaced by SB258585. In vivo brain penetration was good with reproducible distribution at cortical and subcortical levels. The automated method gave the best spatial normalization. The Logan graphical model showed the best tracer binding indices, giving the highest magnitude, lowest standard deviation and best reproducibility and robustness. Finally, 5-HT6R antagonist pre-injection significantly decreased [18F]2FNQ1P binding mainly in the striatum and sensorimotor cortex. Taken together, these preclinical results show that [18F]2FNQ1P is a good candidate to address 5-HT6 receptors in clinical studies.
first_indexed 2024-12-13T22:06:48Z
format Article
id doaj.art-e7dc34cfcd90462aa22c95cde1c49215
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-13T22:06:48Z
publishDate 2017-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-e7dc34cfcd90462aa22c95cde1c492152022-12-21T23:29:49ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122017-07-01810.3389/fphar.2017.00471275664Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 ReceptorsVéronique Sgambato-Faure0Véronique Sgambato-Faure1Thierry Billard2Thierry Billard3Elise Météreau4Elise Météreau5Sandra Duperrier6Sandra Duperrier7Sylvain Fieux8Sylvain Fieux9Nicolas Costes10Léon Tremblay11Léon Tremblay12Luc Zimmer13Luc Zimmer14Luc Zimmer15Luc Zimmer16Université Claude Bernard Lyon ILyon, FranceInstitut des Sciences Cognitives Marc Jeannerod, CNRS UMR5229Bron, FranceUniversité Claude Bernard Lyon ILyon, FranceInstitut de Chimie et de Biochimie, CNRS UMR5246Villeurbanne, FranceUniversité Claude Bernard Lyon ILyon, FranceInstitut des Sciences Cognitives Marc Jeannerod, CNRS UMR5229Bron, FranceUniversité Claude Bernard Lyon ILyon, FranceInstitut des Sciences Cognitives Marc Jeannerod, CNRS UMR5229Bron, FranceUniversité Claude Bernard Lyon ILyon, FranceCentre de Recherche en Neurosciences de Lyon, CNRS UMR5292, INSERM U1028Lyon, FranceCERMEP-Imagerie du VivantLyon, FranceUniversité Claude Bernard Lyon ILyon, FranceInstitut des Sciences Cognitives Marc Jeannerod, CNRS UMR5229Bron, FranceUniversité Claude Bernard Lyon ILyon, FranceCentre de Recherche en Neurosciences de Lyon, CNRS UMR5292, INSERM U1028Lyon, FranceCERMEP-Imagerie du VivantLyon, FranceHospices Civils de LyonLyon, FranceBrain serotonin-6 receptor (5-HT6R) is the one of the most recently identified serotonin receptors. Accumulating evidence suggests that it is a potent therapeutic target for psychiatric and neurological diseases. Since [18F]2FNQ1P was recently proposed as the first fluorinated positron emission tomography (PET) radioligand for this receptor, the objective of the present study was to demonstrate its suitability for 5-HT6R neuroimaging in primates. [18F]2FNQ1P was characterized by in vitro autoradiography and in vivo PET imaging in cynomolgus monkeys. Following in vivo PET imaging, tracer binding indices were computed using the simplified reference tissue model and Logan graphical model, with cerebellum as reference region. The tracer binding reproducibility was assessed by test–retest in five animals. Finally, specificity was assessed by pre-injection of a 5-HT6R antagonist, SB258585. In vitro, results showed wide cerebral distribution of the tracer with specificity toward 5-HT6Rs as binding was effectively displaced by SB258585. In vivo brain penetration was good with reproducible distribution at cortical and subcortical levels. The automated method gave the best spatial normalization. The Logan graphical model showed the best tracer binding indices, giving the highest magnitude, lowest standard deviation and best reproducibility and robustness. Finally, 5-HT6R antagonist pre-injection significantly decreased [18F]2FNQ1P binding mainly in the striatum and sensorimotor cortex. Taken together, these preclinical results show that [18F]2FNQ1P is a good candidate to address 5-HT6 receptors in clinical studies.http://journal.frontiersin.org/article/10.3389/fphar.2017.00471/fullPET imagingserotonin5-HT6 receptorstriatumnon-human primate
spellingShingle Véronique Sgambato-Faure
Véronique Sgambato-Faure
Thierry Billard
Thierry Billard
Elise Météreau
Elise Météreau
Sandra Duperrier
Sandra Duperrier
Sylvain Fieux
Sylvain Fieux
Nicolas Costes
Léon Tremblay
Léon Tremblay
Luc Zimmer
Luc Zimmer
Luc Zimmer
Luc Zimmer
Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors
Frontiers in Pharmacology
PET imaging
serotonin
5-HT6 receptor
striatum
non-human primate
title Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors
title_full Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors
title_fullStr Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors
title_full_unstemmed Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors
title_short Characterization and Reliability of [18F]2FNQ1P in Cynomolgus Monkeys as a PET Radiotracer for Serotonin 5-HT6 Receptors
title_sort characterization and reliability of 18f 2fnq1p in cynomolgus monkeys as a pet radiotracer for serotonin 5 ht6 receptors
topic PET imaging
serotonin
5-HT6 receptor
striatum
non-human primate
url http://journal.frontiersin.org/article/10.3389/fphar.2017.00471/full
work_keys_str_mv AT veroniquesgambatofaure characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT veroniquesgambatofaure characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT thierrybillard characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT thierrybillard characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT elisemetereau characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT elisemetereau characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT sandraduperrier characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT sandraduperrier characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT sylvainfieux characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT sylvainfieux characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT nicolascostes characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT leontremblay characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT leontremblay characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT luczimmer characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT luczimmer characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT luczimmer characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors
AT luczimmer characterizationandreliabilityof18f2fnq1pincynomolgusmonkeysasapetradiotracerforserotonin5ht6receptors